Ethambutol 100mg tablets

Country: Велика Британија

Језик: Енглески

Извор: MHRA (Medicines & Healthcare Products Regulatory Agency)

Активни састојак:

Ethambutol hydrochloride

Доступно од:

Alliance Healthcare (Distribution) Ltd

АТЦ код:

J04AK02

INN (Међународно име):

Ethambutol hydrochloride

Дозирање:

100mg

Фармацеутски облик:

Oral tablet

Пут администрације:

Oral

Класа:

No Controlled Drug Status

Тип рецептора:

Valid as a prescribable product

Резиме производа:

BNF: 05010900

Информативни летак

_Colours_
_(Printed)_
_Title:_
_Ref:_
_Date:_
_Size (mm):_
_Modified:_
Ethambutol 100mg PIL
Eth/100/10
25/04/20
145x297.5
22/06/20
PROCESS
BLACK
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE.
Keep this leaflet. You may need to read it again. If you have any
further questions, ask your doctor or
pharmacist. This medicine has been prescribed for you. Do not pass it
on to others. It may harm them, even
if their symptoms are the same as yours. If you get any side effects,
talk to your doctor or pharmacist.
This includes any possible side effects not listed in this leaflet.
IN THIS LEAFLET:
1.
What Ethambutol Tablets are and what they are used for
2.
Before you take Ethambutol Tablets
3.
How to take Ethambutol Tablets
4.
Possible side effects
5.
How to store Ethambutol Tablets
6.
Further information
1.
WHAT ETHAMBUTOL TABLETS ARE AND WHAT THEY ARE USED FOR
The name of your medicine is Ethambutol Tablets. Ethambutol belongs to
a group of medicines called
antituberculosis drugs and is used for the treatment and prevention of
tuberculosis, an infectious disease
mainly affecting the lungs.
2.
BEFORE YOU TAKE ETHAMBUTOL TABLETS
DO NOT TAKE ETHAMBUTOL TABLETS:
-
if you have sight problems.
-
if you are allergic (hypersensitive) to ethambutol hydrochloride or
any of the other ingredients (see list
under ‘What Ethambutol Tablets contain’ in section 6).
Problems with your sight
You should have your eyesight checked before taking these tablets. If
you notice any changes to your vision
whilst taking these tablets, YOU SHOULD STOP TAKING THEM AND NOTIFY
YOUR DOCTOR IMMEDIATELY.
In the majority of cases, any changes to vision will return to normal
within a few weeks/months after stopping
treatment, however, in rare cases, it may take longer for eyesight to
recover or the changes may become
permanent.
Take special care with Ethambutol if you have a history of kidney
problems. Before treatment with Ethambutol
you should have your kidneys checked.
If you develop symptoms suggestive of hepatitis (e.g. ab

Карактеристике производа

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Ethambutol 100 mg Tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each film coated tablet contains 100mg Ethambutol Hydrochloride.
For a full list of excipients see section 6.1.
3
PHARMACEUTICAL FORM
Film coated tablet.
Smooth, yellow, circular, biconvex film coated tablet, plain on both
sides.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
The primary treatment and re-treatment of tuberculosis and for
prophylaxis in
cases of inactive tuberculosis or large-tuberculinpositive reaction.
Ethambutol
should only be used in conjunction with other anti-tuberculous drugs
to which
the patient’s organisms are susceptible.
Consideration should be given to official guidance on the appropriate
use of
antibacterial agents
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
_Route of administration_:
Oral
_Posology: _
Recommended Dosage
The dosage of ethambutol must be adjusted according to the body weight
of
the patient.
This drug should not be used as a sole anti-tuberculosis agent, but
should be
given with at least one other antituberculosis drug to avoid
development of
resistant strains.
The usual daily dosage is 15-25mg/kg body weight given as a single
dose.
_ _
_ADULTS _
For primary treatment and prophylaxis: Ethambutol should be
administered in
a single daily dose of 15mg/kg, concomitant drugs being maintained at
their
recommended dosage levels.
For re-treatment: For the first 60 days of treatment, ethambutol
should be
administered in a single daily dose of 25mg/kg. Thereafter the dosage
should
be
reduced
to
15mg/kg,
concomitant
drugs
being
maintained
at
their
recommended dosage levels.
_CHILDREN _
For primary treatment and re-treatment: For the first 60 days of
treatment, a
single daily oral dose of 25mg/kg. Thereafter the dosage should be
reduced to
15mg/kg, concomitant drugs being maintained at their recommended
dosage
levels._ _
For prophylaxis: A single daily oral dose of 15mg/kg, concomitant
drugs
being used at their recommended dosage levels
As chil